Biomega Diagnostic Medicine

What Biomega Diagnostic Medicine does

Biomega Diagnostic Medicine (BIOMEGA MEDICINA DIAGNÓSTICA LTDA.) is a Brazil-based diagnostic medicine outsourcing company founded in 2017 and headquartered in Barueri, São Paulo. The company provides clinical analyses (Análises Clínicas) and pathological anatomy (Anatomia Patológica) — the latter delivered 100% in-house — to public and private hospital networks across 9 Brazilian states and 50+ municipalities. Its operational model combines a 2,200 sqm centralized processing hub (NPC — Núcleo de Processamento Central) housing the largest laboratory automation track in the Americas with distributed peripheral processing units (NPPs) embedded within partner hospitals, plus ambulatory collection points and home collection services.

Biomega processes 54 million diagnostic exams annually through a network of 1,000+ collection points and employs 1,800+ professionals. Its proprietary technology stack includes the Data Analytics Biomega platform (machine learning, statistics, and mathematical algorithms applied to diagnostic data for process optimization), integrated systems for exam ordering and result release connecting hospitals, NPC, and patients, and a custom mobile application for physicians and patients. The company holds ONA III accreditation — the highest level of Brazil's National Accreditation Organization — and Controllab quality certification.

The business model is primarily B2B managed services: long-term contracts with public (SUS) and private hospital networks under which Biomega deploys and operates full in-hospital laboratory operations, covering staffing, equipment, supply chain, logistics, and quality control. A secondary B2C/professional-services revenue stream derives from ambulatory collection units (Valinhos, Campinas, Vinhedo, Monte Mor, São Vicente, Registro) and home collection for individual patients and corporate clients. GTM is enterprise field sales targeting hospital administrators and public health procurement, supplemented by WhatsApp-driven scheduling and a corporate website. No public pricing is listed; services are billed via hospital contracts, SUS reimbursement, or private insurance on a quote-based model.

Name

Biomega Diagnostic Medicine

Legal name

BIOMEGA MEDICINA DIAGNÓSTICA LTDA.

Website

https://biomega.com.br

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Biomega Diagnostic Medicine is a Brazil-based, privately held diagnostic laboratory outsourcing company that delivers clinical analyses and in-house pathological anatomy to public and private hospital networks across 9 states, operating a centralized 2,200 sqm processing hub and 1,000+ collection points serving 54 million exams annually.

Ownership category

akta.pro rank

Product category

Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

akta.pro secondary industries

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

• Clinical laboratory services
• Diagnostic medicine outsourcing
• Pathological anatomy services
• Hospital laboratory management
• Medical diagnostic testing

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Hospital Laboratory Outsourcing Services: B2B contract model where Biomega operates and manages full in-house diagnostic laboratory operations (analyses cliniques and anatomical pathology) within partner hospitals, including staffing, equipment, supplies, logistics, and quality management. Revenue is derived from service contracts with public hospital networks and private hospital groups.
2. Ambulatorial and Home Collection Services: Outpatient collection points and home collection services for individual patients and corporate clients (e.g., admission/periodic employee exams). Revenue generated per test or as part of corporate health packages.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels2 records

Core offering

Biomega Diagnostic Medicine provides outsourced clinical analyses (hematology, immunochemistry, microbiology, molecular biology, flow cytometry, etc.) and in-house pathological anatomy services to public and private hospitals across Brazil. The company operates a 2,200 sqm central processing hub (NPC), embeds peripheral processing labs (NPP) inside partner hospitals, and runs ambulatory collection units and home collection services for individual patients.

Product overview

Biomega Diagnostic Medicine operates as a diagnostic medicine provider offering outsourced clinical laboratory and pathological anatomy services to hospitals. The portfolio consists of core laboratory services (Análises Clínicas and Anatomia Patológica 100% internal), operational modules (NPP peripheral processing units installed in hospitals, outpatient collection points, and home collection services), infrastructure (Central Processing Hub/NPC), analytics capabilities (Data Analytics tool), and patient-facing digital interfaces (results portal and mobile APP). The company serves public and private hospital networks across 9 Brazilian states with 24/7 operations.

Differentiator

Problem solved

Functional benefit

Products and services

• Análises Clínicas (Clinical Analyses)

Quantifiable outcome

• 54 million diagnostic exams processed annually across the network
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Alliar: Brazilian diagnostics chain combining imaging and laboratory services, serving hospitals and ambulatory patients; competes with Biomega in the outsourced diagnostic medicine segment.
• Hermes Pardini: Large Brazilian diagnostic laboratory offering clinical analyses and pathology to hospitals and patients, with strong regional density — a direct competitive peer in outsourced diagnostics.
• Fleury: Major Brazilian diagnostic medicine network offering clinical analyses, pathology, and hospital lab services; competes with Biomega for private hospital contracts and ambulatory patients.
• Sabin Diagnósticos e Saúde: Brazilian diagnostics group with hospital lab outsourcing and ambulatory collection units across multiple states — directly comparable scale and business model to Biomega.
• Dasa: Largest diagnostic medicine company in Brazil, operating hospital lab outsourcing, ambulatory collection, and anatomic pathology services — directly comparable to Biomega across the full stack.

Broad incumbents

• Grupo Fleury: Diversified diagnostic medicine incumbent in Brazil offering hospital lab services, ambulatory, and specialty testing; competes with Biomega across both B2B outsourcing and ambulatory channels.
• Diagnósticos da América (Dasa): Incumbent leader in Brazilian diagnostics with a broad portfolio spanning hospitals, ambulatory, and B2B lab outsourcing — overlaps Biomega's hospital outsourcing GTM at much larger scale.

Emerging players

• Hilab: Brazilian emerging diagnostic player focused on remote/point-of-care and home-collection testing — adjacent to Biomega's home collection service with overlapping target customers.
• Labpack Diagnóstica: Brazilian emerging laboratory offering outsourced diagnostic testing to hospitals and ambulatory patients; partially comparable to Biomega's NPP outsourcing model at smaller scale.

Regional players

• Centro de Diagnósticos Brasil (CDB): São Paulo–based regional diagnostics provider offering clinical analyses and imaging — overlaps Biomega's ambulatory and hospital lab footprint in the São Paulo market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/biomegamedicinadiagnostica
• LinkedInlinkedin.com/company/biomegamedicinadiagnostica

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biomega Diagnostic Medicine